id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_ovwfhshipvdmtczjfk4mhb3qfm	John E M Midgley	Variation in the biochemical response to l-thyroxine therapy and relationship with peripheral thyroid hormone conversion efficiency	2015	10	.pdf	application/pdf	7483	1016	61	carcinoma group (nZ143), even after adjusting for different TSH levels. thyroid carcinoma patients (nZ50) received 1.57 mg/kg per day L-T4 (IQR 1.40, 1.69), compared apparent; some patients with fully suppressed TSH failed to raise FT3 above the median level. These findings imply that thyroid hormone conversion efficiency is an important modulator of the L-T4 dose with clinical categories and biochemical outcomes such as TSH, FT4 and FT3 levels. dose requirements of L-T4 including conditioning modulators, thyroid hormone conversion efficiency and analysis, 353 patients on thyroid hormone replacement carcinoma patients received significantly higher doses of carcinoma patients compared to autoimmune thyroiditis TSH (A) or FT3 (B) vs weight-adjusted L-T4 dose in three groups of patients groups were similar (PO0.1) in their age, BMI, weightadjusted L-T4 dose and TSH levels except for men being TSH in autoimmune thyroiditis or benign disease post At both comparable levels of TSH suppression or similar FT3 concentrations, athyreotic thyroid carcinoma patients were	./cache/work_ovwfhshipvdmtczjfk4mhb3qfm.pdf	./txt/work_ovwfhshipvdmtczjfk4mhb3qfm.txt